CA 125 is an epithelial membrane marker which can be detected in the serum of patients with ovarian cancer and which may reflect tumour burden. In a group of 42 patients, the level of this marker has also been shown to be significantly related to survival.
BastR.C., KlugT.L., St JohnE.A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med1983; 309: 883–7
2.
PatelK.J., ParkerD., Harnden-MayorP., NaylorB.CA 125 and CA 153 as tumour markers in clinical practice. Br J Cancer1986; 54: 216
3.
BagshaweK.D.Risk and prognostic factors in trophoblastic neoplasia. Cancer1976; 38: 1373–5
4.
Germa-LluchJ.R., BegentR.H.J., BagshaweK.D.Tumour marker levels and prognosis in malignant teratoma of the testis. Br J Cancer1980; 42: 850–5
